Blood Cancer Awareness Month: Raise Awareness!


The IMF Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024 With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the question: "Do You Know Myeloma?" Explore the IMF’s Blood Cancer Awareness Month website for infographics on myeloma facts, research breakthroughs in myeloma treatment, and inspirational stories of hope and resilience from those living with the disease. We encourage you to download them from the IMF’s social media tool kit and share them in social media while using the hashtag #kNOwMyeloma. Read the full press release to learn more.


IMF Holds Brian D. Novis Research Grant 2024 Awards Reception and Dinner in Los Angeles At the culmination of the Patient and Family Seminar (PFS) in Los Angeles, the International Myeloma Foundation held the Brian D. Novis (BDN) Research Grant 2024 Reception and Dinner on Saturday, August 17 at the Sheraton Universal Los Angeles in North Hollywood. This year’s BDN junior grant recipients are Martin Gazvoda, PhD, of the University of Ljubljana in Slovenia (organized by Kent Oliver and funded by Laughs for Life); and Alireza Gholipour, PhD, of Massachusetts General Hospital in Boston (organized by Ron and Sheree Pask; funded by Miracles for Myeloma 5K Run/Walk). The BDN senior grant was awarded to Mark Bustoros, MD, of Weill Cornell Medical College in New York (organized by Pam Poliakoff and the IMF; funded by Miles for Myeloma 5K Run/Walk and Inland Empire 5K Run/Walk for Myeloma Miracles). Know more about this year's grant recipients and their research projects from the news release.


Follow Us on Our Journey: The Inaugural Iceland Cycling Expedition Is Underway! The Iceland Cycling Expedition (ICE) is a fundraising bike tour taking place in beautiful Iceland with a team of twelve cyclists. This morning, 12 intrepid individuals kicked off their journey across Iceland to support the Black Swan Research Initiative®, including the iStopMM Research Project in Iceland. Follow along from the button below and donate to support the thrill of adventure while being an agent for change.


Don't Miss Our Live Q&A with Dr. Urvi A. Shah: Nutrition and Myeloma Management Join Dr. Urvi A. Shah, a renowned expert from Memorial Sloan Kettering Cancer Center, on Tuesday, September 3rd, 2024, at 4:00 p.m. PST \| 7:00 p.m. EST, for a live Q&A focused on the role of nutrition in myeloma management. Gain valuable insights into dietary choices, insights about supplements, and overall well-being for patients with multiple myeloma. This Facebook Live event is part of our Blood Cancer Awareness Month #kNOwMyeloma awareness campaign. Share it with your friends and family and learn about myeloma together.


Watch the Replay: Hot Topics in Myeloma At the mid-August IMF Patient and Family Seminar in Los Angeles, IMF Chief Medical Officer Dr. Joseph Mikhael discussed recent advancements and changes in myeloma treatment strategies, emphasizing the importance of education, connection, and inspiration for patients. He highlighted three key developments: the trend towards using multiple drugs upfront in treatment, the potential resurgence of belantamab mafodotin (Blenrep), and the concept of "less is more" in drug dosing. Watch the replay now.


Around the Web: Myeloma News To keep you abreast of the most recent myeloma research findings, “The Myeloma Minute” features links to top myeloma content around the web. This article “Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel” in Blood Cancer Journal with Dr. Rahul Banerjee as the lead author, includes contributions from the IMF’s President and CEO Yelak Biru and IMF Nurse Leadership Board member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO. A panel of experts hosted by Cancer Network discuss the topic “Quadruplet Therapy May Be the New Frontline Standard of Care in Multiple Myeloma.” As always, we invite you to visit the IMF Newsroom for the latest myeloma news.

Week in Review Blogs by Dr. Durie

Ask Dr. Durie Videos

Online Patient Forum

Smart Patients: Join the Conversation

Clinical Trial Fact Sheets

KTX-1001 (phase I trial – Now Accruing)

Phase II Relapsed or Refractory Venetoclax Trial (Fully Accrued)

CANOVA Trial (Fully Accrued)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Replays and Events

Register Now
12th Annual Miracles for Myeloma 5K Hybrid Run/Walk

Donate to the Fundraiser
Hole in One for Multiple Myeloma – A Golf Tournament

Watch the Replay
Living Well with Myeloma on 2024 Medicare Changes

See also, all of our events.

We Thank Our Sponsors:

Abbvie Inc., GSK, Johnson & Johnson, Karyopharm Therapeutics, Regeneron, and Sanofi

We also thank individuals like you for your continued support!

Join the conversation at The International Myeloma Foundation

Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma

www.myeloma.org

This email was sent to by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
1-800-452-2873

We respect your privacy and your preferences for communications of this nature.
Home • Unsubscribe • Manage Subscriptions • Privacy Policy

View as web page